Response to McGirr et al.'s Comment on “Clinical and Economic Impact of a Potential Switch from 13-Valent to 10-Valent Pneumococcal Conjugate Infant Vaccination in Canada”

Detalles Bibliográficos
Autores principales: Wilson, Michele R., Wasserman, Matt, Jadavji, Taj, Postma, Maarten, Breton, Marie-Claude, Peloquin, Francois, Earnshaw, Stephanie R., McDade, Cheryl, Sings, Heather L., Farkouh, Raymond
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2018
Materias:
Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6249185/
https://www.ncbi.nlm.nih.gov/pubmed/30411203
http://dx.doi.org/10.1007/s40121-018-0221-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6249185/
https://www.ncbi.nlm.nih.gov/pubmed/30411203
http://dx.doi.org/10.1007/s40121-018-0221-2

Ejemplares similares